Andrew J. Armstrong, Elena Castro Marcos, Stéphane Oudard, Xin Gao, Nianzeng Xing, Shilpa Gupta, Farhat Ghaznawi, Karin Burock, Giorgio G. Galli, Arun Azad. "TulmiSTAR-01: A phase I/II dose optimization study of tulmimetostat in combination with luxdegalutamide versus standard of care (SOC) in patients (pts) with progressive metastatic castrate-resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps301